Navigation Links
Cenestra Health Issued Notice of Allowance: Expands Patent Range of High-Purity Omega-3 Fatty Acid Formulations
Date:9/19/2011

for cardiovascular disease, depression and inflammation-based illnesses..

Omega-3-acid ethyl esters represent a class of medications called lipid-regulating agents. Prescription omega-3s are used together with lifestyle changes (i.e., weight loss, diet) to reduce the amount of triglycerides by decreasing the amount of fats made in the liver. The FDA has approved a number of prescription drugs to treat elevated triglycerides, including an omega-3 ethyl ester medication.

About Cenestra, LLC (D/B/A Cenestra Health)

Cenestra Health is a privately-held and unleveraged biopharmaceutical company based in New Haven, Connecticut. Cenestra Health was founded in 2005 to formulate, develop and market "best-in-class" proprietary natural products with applications in the OTC, medical food and pharmaceutical markets. Cenestra Health is focused on the clinical development of its late stage clinical drug candidates for the treatment of dyslipidemias and central nervous system disorders. Cenestra Health is planning to initiate  Phase 3 registrational trials in early 2012.

About Omega-3 Essential Fatty Acids

Omega-3 fatty acids are considered "essential" fatty acids (EFAs) as they are necessary to human health but cannot be produced by the body. The two major health promoting omega-3 polyunsaturated fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA and DHA have been shown to promote good physical and emotional health, reduce the risk of cardiovascular disease, and exert powerful anti-inflammatory effects. Omega-3 prescriptions in the United States alone accounted for over $1 billion dollars in sales in 2010.

Statements made in this press release should not to be construed as making any specific claim or claims in the diagnosis, prevention or treatment of any disease or disorder but  may relate to historical facts and information that reflect forward looking sta
'/>"/>

SOURCE Cenestra Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Healthpoint Biotherapeutics to Present at UBS Global Life Sciences Conference
2. GNS Healthcare, Inc Collaborates with Nationally Ranked Hospital to Predict Adverse Drug Events and Hospital Readmissions
3. Health fears over CO2 storage are unfounded, study shows
4. Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc
5. Tengion to Present at Rodman & Renshaw 13th Annual Healthcare Conference
6. Anadys Pharmaceuticals Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
7. Chimerix to Present at Stifel Nicolaus 2011 Healthcare Conference
8. Clinical Integration Enables Leading Health Systems to Deliver Higher Quality, Cost-Effective Care
9. Omeros to Present at Rodman and Renshaw 13th Annual Healthcare Conference
10. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
11. Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , September 16, 2014 BCC ... MARKET FOR STEM CELLS , the global market for ... billion by 2018, with a five-year compound annual growth ... witnessed in the Americas with growth projections of $2.2 ...      (Logo: http://photos.prnewswire.com/prnh/20140805/700528) , Unlike other ...
(Date:9/15/2014)... Cancer Immunotherapy Market : ... Therapies is a new market research report announced ... principal types of therapeutics that have become the ... immunotherapy (which is often called "immuno-oncology") in recent ... cellular immunotherapy. , The regular use of ...
(Date:9/15/2014)... made of carbon nanotubes is neat, but Rice University scientists ... nanotubes in new fibers created at Rice line up like ... chemist Angel Mart and his colleagues. , The tricky bit, ... in the journal ACS Nano , is keeping the ... fiber. , Left to their own devices, carbon nanotubes form ...
(Date:9/15/2014)... 15, 2014 Research and Markets has ... by Product, by Services, by Technology, by Application - Global ... Whole Exome Sequencing (WES) is next-generation technology used for ... exon. The exome, which is the total of all exons ... and is actually converted into proteins after translation. It is ...
Breaking Biology Technology:Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 2Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 3
... 2011 Cephalon, Inc., (Nasdaq: CEPH ) will hold ... founder and late Chairman and CEO on February 1, 2011, at ... Street, Philadelphia, Pennsylvania. Dr. Baldino founded Cephalon in ... one of the top ten biotechnology companies in the world. He ...
... Calif., Jan. 24, 2011 Genesis Biopharma, Inc. (OTC ... company developing targeted cancer therapies, today announced the ... for Industry Codevelopment of Two or More Unmarketed ... document, designed to encourage companies to collaborate and ...
... Leading organizations understand the value of using market research ... numerous functions. As pharmaceutical, biotechnology and medical device companies ... and develop new capabilities while refining current ones to ... The Future of Market Research: Challenges and Changes in ...
Cached Biology Technology:Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D. 2Genesis Biopharma Expresses Support for FDA Codevelopment Guidelines 2Role of Market Research Evolving to Take on a More Strategic Responsibility 2
(Date:9/15/2014)... A new strategic vision document, released today ... Program, describes the long-term goals, objectives, and strategies ... of work over the next five years (2015-2020). ... initial, short-term activities, to be funded in 2015, ... science policy fellowships. , The $500 million, ...
(Date:9/15/2014)... for the first 500 million years after it formed ... complete with oceans, continents and active crustal plates. , ... the Hadean, has gained substantial new support from the ... than 4 billion years ago with those formed contemporaneously ... geological analog for early Earth. , The study was ...
(Date:9/15/2014)... agility are hallmarks of the cheetah: The big predator is ... 60 mph in just a few seconds. As it ramps ... tandem, bounding until it reaches a full gallop. , Now ... successfully implemented in a robotic cheetah a sleek, four-legged ... as much as its feline counterpart. The team recently took ...
Breaking Biology News(10 mins):NAS Gulf Research Program announces strategic vision, initial opportunities 2NAS Gulf Research Program announces strategic vision, initial opportunities 3NAS Gulf Research Program announces strategic vision, initial opportunities 4Early Earth less hellish than previously thought 2Early Earth less hellish than previously thought 3Run, cheetah, run 2Run, cheetah, run 3
... diseases such as schizophrenia, major depression and cancer ... of dysfunctional genes. A novel computational biology method ... Abdi, PhD, http://www.njit.edu/news/2008/2008-367.php , associate professor in ... found a way to uncover the critical genes ...
... day Americans elect a new president, one of the nation,s ... Houston and outline the daunting global warming challenges awaiting the ... analysis at the National Center for Atmospheric Research (NCAR) in ... a colloquium Tuesday, Nov. 4. The event is free ...
... granted to the laboratory of William Roush, Ph.D., ... Research Institute. Other participants in the consortium are ... California, San Francisco (UCSF), and University of Washington. ... Translational Research Institute Medical Chemistry division and professor ...
Cached Biology News:NJIT professor finds engineering technique to identify disease-causing genes 2Climate change expert to discuss grim global warming predictions 2Scripps Florida scientists awarded $1.5M to fight major water and food parasites 2
... IEF cell is an apparatus dedicated to ... or agarose slab gels. The cell includes ... casting tray, 5 glass plates, 50 sheets ... sample templates, and instructions. Dimensions are 21 ...
... The Biomek FX provides complete ... applications. With 96-, 384-, ... heads in either single or ... FX offers maximum speed and ...
BD Falcon, microtest ELISA plate 96 well flat-bottom, clear. Polystyrene, nonsterile, no lid (25/sp, 100/ca) Packaging: 25 / pack, 100 / case ...
... a convenient method to probe conformational changes in ... Thus, the kit may be used to determine ... transport substrates for MDR1. Because UIC2 binding is ... the MDR1 Shift Assay can be utilized for ...
Biology Products: